Fig. 3From: Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapyCorrelation between SpHe-comut status and immune-related features. A–D Comparison of the immune score (A), CYT score (B), MHC-I score (C), and GEP score (D) between the SpHe-comut+ and SpHe-comut− groups. E GSEA plot of significant hallmark pathways in comparison between the SpHe-comut+ and SpHe-comut− groups. ****p < 0.0001Back to article page